Black Friday saleUp to 70% OFF
PPP

PHARMALUNDENSIS AB

No trades
See on Supercharts
Overview
Financials News Discussions Technicals Seasonals

PHAL chart


Full chart

Key stats


Market capitalization
‪19.31 M‬ SEK
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
−0.089 SEK
Net income (FY)
‪−4.40 M‬ SEK
Revenue (FY)
0.00 SEK
Shares float
‪20.22 M‬
Beta (1Y)
1.52

About PHARMALUNDENSIS AB


Sector
Health Technology
CEO
Staffan Skogvall
Headquarters
Lund
Website
pharmalundensis.se
Founded
2007
ISIN
SE0003359710
FIGI
BBG001Y25XV3
PharmaLundensis AB engages in the provision of biotechnology activities. It offers research and development of medicines and treatment for lung diseases such as chronic obstructive pulmonary disease, chronic bronchitis, and influenza. The company was founded by Staffan Skogvall in 2007 and is headquartered in Lund, Sweden.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—
‪0.00‬

PHAL news



Technicals

Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

Frequently Asked Questions


The current price of PHAL is 0.435 SEK — it has increased by 0.53% in the past 24 hours. Watch PHARMALUNDENSIS AB stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NGM exchange PHARMALUNDENSIS AB stocks are traded under the ticker PHAL.
PHAL stock has fallen by −10.33% compared to the previous week, the month change is a −32.75% fall, over the last year PHARMALUNDENSIS AB has showed a −6.65% decrease.
PHAL reached its all-time high on Jun 28, 2013 with the price of 15.845 SEK, and its all-time low was 0.161 SEK and was reached on Jun 28, 2023. View more price dynamics on PHAL chart.
See other stocks reaching their highest and lowest prices.
PHAL stock is 15.71% volatile and has beta coefficient of 1.52. Track PHARMALUNDENSIS AB stock price on the chart and check out the list of the most volatile stocks — is PHARMALUNDENSIS AB there?
Today PHARMALUNDENSIS AB has the market capitalization of ‪19.31 M‬, it has decreased by −11.01% over the last week.
Yes, you can track PHARMALUNDENSIS AB financials in yearly and quarterly reports right on TradingView.
PHAL net income for the last quarter is ‪−1.03 M‬ SEK, while the quarter before that showed ‪−404.53 K‬ SEK of net income which accounts for −154.36% change. Track more PHARMALUNDENSIS AB financial stats to get the full picture.
No, PHAL doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, PHAL shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade PHARMALUNDENSIS AB stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So PHARMALUNDENSIS AB technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating PHARMALUNDENSIS AB stock shows the sell signal. See more of PHARMALUNDENSIS AB technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.